CSGs, Working-Capital

CSG's Working-Capital Ceiling Nearly Doubles, Putting Free Cash Flow in the Firing Line

Published on 11/20/2026 at 17:41 | Editorial boerse-global.de
CSG held its 2026 revenue goal but raised its net working capital ceiling to below 35% of sales from under 20%, shifting focus to cash conversion.
CSG's Working-Capital Ceiling Nearly Doubles, Putting Free Cash Flow in the Firing Line Illustration mit AI erstellt.

CSG has left its 2026 revenue target untouched, but the defence group has quietly widened the amount of money it expects to have tied up in the business — a change that shifts the debate from the top line to what actually drops through to cash.

The company now guides net working capital to below 35% of sales for 2026, against a prior target of under 20%. That near-doubling of the ceiling says nothing about where the ratio will actually land, only how much room CSG has given itself. For shareholders, the reported figure will matter far more than a restated upper bound.

The stock felt the weight of the reassessment. CSG shares were down 7.4% on Friday afternoon and have shed 15% over seven days, leaving them at €9.32 at the last close.

A year of two halves

The 11 November update laid bare how uneven trading has been. Revenue for the first nine months of 2026 rose 6.1% to €4,761 million, yet the third quarter alone saw an 11.7% decline. CSG pointed to deliveries slipping into later periods, which makes the timing of order conversion — not just demand — central to hitting the full-year number.

That same announcement carried the sharper blow: the operating EBIT margin forecast for 2026 was cut from 24% to 25% down to around 21%. Management blamed lower market prices for standard ammunition and a larger contribution from Land Systems. Two separate questions now need answering — how much CSG earns on each euro of revenue, and how much cash remains once the day-to-day business is financed. The margin guidance addresses only the first.

Should investors sell immediately? Or is it worth buying CSG?

Two brokers, one direction

Sell-side opinion has split on where the shares should trade even as both houses moved their targets lower. Petr Bártek of Erste Group Bank cut his price target to €15.6 from €26.1 while keeping a Buy rating. BofA Securities, by contrast, trimmed its objective to €9 from €13 on 13 November and stuck with Sell. The market price sits between the two markers but far closer to BofA's.

J.P. Morgan added its own downgrade on 12 November, moving CSG from Overweight to Neutral and slashing its target to €12 from €27.50, citing concerns over profitability and demand in the ammunition business.

Backlog is not the same as profit

Order intake offers some comfort. CSG put its order backlog at €18 billion, a foundation for future revenue — though it says nothing on its own about how profitably those orders can be executed. The distinction matters: a larger top line helps the valuation less if CSG keeps a thinner slice of it than expected.

The same logic applies to new business. On 12 November, subsidiary Speer Ammunition reported a contract with Canada's Department of National Defence for up to 4.2 million rounds over as many as three years. Useful as a signal of demand, the multi-year framework cannot be equated with revenue or cash receipts in the current year, so it does little to ease near-term working-capital concerns.

What the next report must show

The optimistic reading requires CSG to work through those deferred deliveries and release the capital they have absorbed. Holding the €7.4 billion to €7.6 billion revenue corridor while the net working capital ratio falls would be a far stronger signal for free cash flow than the revenue outlook on its own.

The gloomier path needs no revenue miss at all. More cash could stay locked in the operating business while weaker ammunition pricing erodes profitability, leaving CSG to hit its sales target without a matching improvement in cash generation. Deferred deliveries can, in principle, be caught up; softer demand cannot be fixed by simply moving a shipment date.

When the 2026 figures land, the test is whether order conversion comes with capital release. A falling working-capital ratio alongside a maintained revenue range would support the constructive case. A ratio that stays elevated would counsel caution on free cash flow even if the sales target is met — and whether CSG reaches its trimmed margin expectation in the same breath will determine if the backlog still counts as an argument for a higher valuation.

Ad

CSG Stock: New Analysis - 20 November

Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated CSG analysis...

Disclaimer...
en | NL0015073TS8 | CSGS | boerse | 70540650 |